Need professional-grade analysis? Visit stockanalysis.com
$9.45B
85.18
1,947
1.17%
China Resources Boya Bio pharmaceutical Group Co Ltd (300294) trades on SHE in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY18.84, down 1.10% from the previous close.
Over the past year, 300294 has traded between a low of CNY18.51 and a high of CNY27.50. The stock has lost 31.2% over this period. It is currently 31.5% below its 52-week high.
China Resources Boya Bio pharmaceutical Group Co Ltd has a market capitalization of $9.45B, with a price-to-earnings ratio of 85.18 and a dividend yield of 1.17%.
China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the research, development, production, and sale of blood products in China. It offers blood products, such as human serum albumin; human, intravenous, freeze-dried intravenous, hepatitis B, tetanus, and rabies immunoglobulin; and human fibrinogen, prothrombin complex, and coagulation factor VIII. The company also provides compound bone peptide, oxytocin, heparin sodium injection, posterior pituitary, and carboprost tromethamine injection. In addition, it engages in research, development, production, and sales of anti-infective, diabetes, and cardiovascular drugs. The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co.,Ltd. The company was founded in 1993 and is based in Fuzhou, China.
Side-by-side comparison against top Healthcare peers.